Table 4 Relationship between COCN and clinicopathological features of patients with CRC
From: Prognostic value of the NLR combined with CIP2A in the serum of patients with colorectal cancer
COCN | |||||
|---|---|---|---|---|---|
Variable | 2 | 1 | 0 | P | |
Gender | 0.237 | ||||
Female | 5 | 12 | 13 | ||
Male | 10 | 13 | 8 | ||
Age | 0.914 | ||||
 < 65 | 7 | 15 | 16 | ||
 ≥ 65 | 8 | 10 | 5 | ||
Location | 0.914 | ||||
Colon | 5 | 10 | 8 | ||
Rectum | 10 | 15 | 13 | ||
T stage | 0.939 | ||||
T1–T2 | 8 | 13 | 12 | ||
T3–T4 | 7 | 12 | 9 | ||
N stage | 0.454 | ||||
N0 | 11 | 15 | 16 | ||
N1–N2 | 4 | 10 | 5 | ||
M stage | 0.089 | ||||
M0 | 12 | 20 | 21 | ||
M1 | 3 | 5 | 0 | ||
Intestinal obstruction | 0.859 | ||||
No | 13 | 20 | 17 | ||
Yes | 2 | 5 | 4 | ||
CEA |  < 0.001 | ||||
 ≥ 5 | 3 | 20 | 20 | ||
 < 5 | 12 | 5 | 1 | ||
CA19-9 | 0.001 | ||||
 ≥ 37 | 5 | 18 | 19 | ||
 < 37 | 10 | 7 | 2 | ||
CIP2A |  < 0.001 | ||||
Low | 0 | 12 | 21 | ||
High | 15 | 13 | 0 | ||
NLR |  < 0.001 | ||||
 < 2.03 | 0 | 13 | 21 | ||
≧ 2.03 | 15 | 12 | 0 | ||